Order Article Reprints

Lassche G, Tada Y, van Herpen CML, Jonker MA, Nagao T, Saotome T, Hirai H, Saigusa N, Takahashi H, Ojiri H, et al. Predictive and Prognostic Biomarker Identification in a Large Cohort of Androgen Receptor-Positive Salivary Duct Carcinoma Patients Scheduled for Combined Androgen Blockade. Cancers. 2021; 13(14):3527. https://doi.org/10.3390/cancers13143527

Lassche, Gerben, Yuichiro Tada, Carla M. L. van Herpen, Marianne A. Jonker, Toshitaka Nagao, Takashi Saotome, Hideaki Hirai, Natsuki Saigusa, Hideaki Takahashi, Hiroya Ojiri, and et al. 2021. "Predictive and Prognostic Biomarker Identification in a Large Cohort of Androgen Receptor-Positive Salivary Duct Carcinoma Patients Scheduled for Combined Androgen Blockade" Cancers 13, no. 14: 3527. https://doi.org/10.3390/cancers13143527

Lassche, G., Tada, Y., van Herpen, C. M. L., Jonker, M. A., Nagao, T., Saotome, T., Hirai, H., Saigusa, N., Takahashi, H., Ojiri, H., van Engen-Van Grunsven, A. C. H., Schalken, J. A., Fushimi, C., & Verhaegh, G. W. (2021). Predictive and Prognostic Biomarker Identification in a Large Cohort of Androgen Receptor-Positive Salivary Duct Carcinoma Patients Scheduled for Combined Androgen Blockade. Cancers, 13(14), 3527. https://doi.org/10.3390/cancers13143527